| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_059babf90e455b4228aeb41f2eed9887 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 |
| filingDate |
2016-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_722ce2c59ed7c893a95890304a52eb03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9eb21ebc838aa9b0ae712905b1642e6 |
| publicationDate |
2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9683000-B2 |
| titleOfInvention |
Carbonate prodrugs and methods of using the same |
| abstract |
The present invention provides carbonate prodrugs which comprise a carbonic phosphoric anhydride prodrug moiety attached to the hydroxyl or carboxyl group of a parent drug moiety. The prodrugs may provide improved physicochemical properties over the parent drug. Also provided are methods of treating a disease or condition that is responsive to the parent drug using the carbonate prodrugs, as well as kits and unit dosages. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10377779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11136342-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10442826-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021498-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9981998-B2 |
| priorityDate |
2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |